文献速递肺结节与肺癌

多中心示范筛查试点中低剂量CT肺癌筛查的心理结局:Lung Screen Uptake Trial(LSUT)

Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).
PubMed 文献 · Thorax · 2020-10-21

在真实世界筛查示范试点中,787名60-75岁现吸烟或曾吸烟者于T0(预约时)、T1(次日)、T2(3个月)完成肺癌担忧测评,T0和T2完成焦虑抑郁测评;另383名同年龄吸烟特征但不知晓筛查的社区样本仅完成一次(T0)测评。与社区样本相比,筛查样本肺癌担忧T0和T2、焦虑T0和T2、抑郁T2的均值在调整分析中显著升高;不确定结果、偶发发现及不符合筛查条件者得分最高;平均分仍在临床正常范围内。

要点

  • 真实世界LDCT筛查中高风险个体心理困扰升高,但总体差异不太可能具有临床意义。
  • 不确定结果、偶发发现及不符合筛查条件者心理得分最高。
  • 需纵向监测不同场景及易出现临床显著困扰亚组的心理影响。

核心结论

  • 真实世界LDCT筛查中高风险个体心理困扰升高,但总体差异不太可能具有临床意义。
  • 不确定结果、偶发发现及不符合筛查条件者心理得分最高。
  • 平均分仍在临床正常范围内。

研究设计与样本

  • 真实世界筛查示范试点,筛查样本为787名60-75岁现吸烟或曾吸烟者,社区样本为383名同年龄吸烟特征但不知晓筛查者。
  • 筛查样本在T0(预约时)、T1(次日)、T2(3个月)完成肺癌担忧测评,T0和T2完成焦虑抑郁测评;社区样本仅T0完成一次。
  • 按样本类型和LDCT结果比较均值。

主要发现

  • 与社区样本(T0)相比,筛查样本肺癌担忧T0和T2均值在调整分析中显著升高:T0为11.34(95%CI 11.09-11.59)vs 9.32(8.96-9.69),T2为11.88(11.49-12.27)。
  • 焦虑T0和T2均值升高:T0为4.73(4.42-5.04)vs 3.32(2.94-3.70),T2为5.78(5.33-6.23)。
  • 抑郁T2均值升高:4.15(3.76-4.55)vs 3.85(3.44-4.27)。
  • 不确定结果者T2焦虑均值6.93(5.65-8.21),偶发发现需基层随访者5.34(4.67-6.02),不符合筛查条件者6.51(5.25-7.77),得分最高。
  • 女性、较年轻、无有偿工作、未与伴侣结婚/同居及较低教育水平预测T0心理结局较差,但调整基线得分后不预测T2。

临床怎么用

  • 筛查服务应关注不确定结果、偶发发现及不符合筛查条件者的心理困扰。
  • 对女性、较年轻、无有偿工作、未与伴侣同居及低教育水平者可在T0加强心理支持。
  • 需纵向监测不同场景及易出现临床显著困扰亚组的心理影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies of psychological burden in low-dose CT (LDCT) lung cancer screening trials may lack generalisability due to participation bias and control arms having elevated distress. METHODS: Current and former smokers (n=787, aged 60-75) within a real-world screening demonstration pilot completed measures of lung cancer worry at three time points (T0: appointment, T1: next day, T2: 3 months) and anxiety and depression at two time points (T0 and T2). A 'screening unaware' community sample (n=383) with the same age and smoking characteristics completed these measures once (T0). Mean scores were compared by sample type and LDCT result. RESULTS: Compared with the community sample (T0), mean scores were higher in the screening sample, and statistically significantly increased in adjusted analyses, for lung cancer worry at T0 and T2 (mean (M): 9.32; 95% CI 8.96 to 9.69 vs M: 11.34; 11.09 to 11.59 and M: 11.88; 11.49 to 12.27), for anxiety at T0 and T2 (M: 3.32; 2.94 to 3.70 vs M: 4.73; 4.42 to 5.04 and M: 5.78; 5.33 to 6.23) and depression at T2 (M: 3.85; 3.44 to 4.27 vs M: 4.15; 3.76 to 4.55). Scores were highest for those with indeterminate (eg, T2 anxiety M: 6.93; 5.65 to 8.21) and incidental findings (primary care follow-up M: 5.34; 4.67 to 6.02) and those ineligible for screening (M: 6.51; 5.25 to 7.77). Being female, younger, not in paid employment, not married/cohabiting with a partner and lower education predicted poorer psychological outcomes at T0, but not T2 after adjusting for baseline scores. Mean scores remained within 'normal' clinical ranges. CONCLUSION: Psychological distress was raised among high-risk individuals undergoing LDCT screening in a real-world setting, but overall differences were unlikely to be clinically meaningful. It will be critical to monitor the psychological impact of services longitudinally across diverse settings, including subgroups vulnerable to clinically elevated distress. TRIAL REGISTRATION: The Lung Screen Uptake Trial was registered prospectively with the International Standard Registered Clinical/soCial sTudy (ISRCTN) (Number: ISRCTN21774741) on 23 September 2015 and the National Institutes of Health ClinicalTrials.gov database (NCT02558101) on 22 September 2015.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Kummer S, Waller J, Ruparel M, et al. Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT). Thorax. 2020. PMID: 33087548. doi:10.1136/thoraxjnl-2020-215054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。